These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 22841231

  • 1. Hepatitis B surface antigen positivity is not a contraindication for living kidney donation.
    Tuncer M, Tekin S, Yücetin L, Şengül A, Demirbaş A.
    Transplant Proc; 2012; 44(6):1628-9. PubMed ID: 22841231
    [Abstract] [Full Text] [Related]

  • 2. Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience.
    Tatar E, Turan MN, Firat O, Sezer TO, Sozbilen M, Solak I, Toz H, Hoscoskun C.
    Transplant Proc; 2012; 44(6):1601-3. PubMed ID: 22841224
    [Abstract] [Full Text] [Related]

  • 3. Donors With Hepatitis B Surface Antigen Positivity.
    Asuman Yavuz H, Tekin S, Yuksel Y, Ateş I, Yucetin L, Demir M, Uygun B, Tuncer M, Demirbas A.
    Transplant Proc; 2015 Jun; 47(5):1312-4. PubMed ID: 26093707
    [Abstract] [Full Text] [Related]

  • 4. Comparison of paired exchange kidney transplantations with living related kidney transplantations.
    Tuncer M, Tekin S, Yücetin L, Şengül A, Demirbas A.
    Transplant Proc; 2012 Jun; 44(6):1626-7. PubMed ID: 22841230
    [Abstract] [Full Text] [Related]

  • 5. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [Abstract] [Full Text] [Related]

  • 6. Donor-recipient age difference and graft survival in living donor kidney transplantation.
    Lee YJ, Chang JH, Choi HN, Jung JY, Kim YS, Chung WK, Park YH, Lee HH.
    Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
    [Abstract] [Full Text] [Related]

  • 7. What kind of changes occurred in clinical characteristics of deceased kidney donor recipients after national allocation system in Turkey? A single-center retrospective analysis.
    Solak I, Sezer TO, Toz H, Tatar E, Sozbilen M, Firat O, Hoscoskun C.
    Transplant Proc; 2012 Jan; 44(6):1598-600. PubMed ID: 22841223
    [Abstract] [Full Text] [Related]

  • 8. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 9. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F, Bunnapradist S, Martin P.
    J Nephrol; 2002 Dec; 15(6):605-13. PubMed ID: 12495272
    [Abstract] [Full Text] [Related]

  • 10. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V, Ingsathit A, Jirasiritham S.
    Transplant Proc; 2009 Dec; 41(1):213-5. PubMed ID: 19249516
    [Abstract] [Full Text] [Related]

  • 11. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M, Puliatti C, Macarone M, Cappello D, Gagliano M, Spataro M, Di Mare M, Giuffrida G, Veroux P.
    Transplant Proc; 2005 Dec; 37(6):2467-8. PubMed ID: 16182711
    [Abstract] [Full Text] [Related]

  • 12. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I, Aydin C, Yigit B, Turkmen F, Titiz IM, Altaca G.
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis B surface antigen.
    Patel HV, Kute VB, Vanikar AV, Shah PR, Gumber MR, Jain SH, Engineer DP, Ghelani GH, Trivedi HL.
    Transplant Proc; 2012 Jan; 44(1):72-4. PubMed ID: 22310582
    [Abstract] [Full Text] [Related]

  • 14. Early renal transplantation after donor renal angiography affects initial graft function.
    Tutal E, Canver B, Can S, Colak T, Sezer S, Haberal M.
    Transplant Proc; 2012 Jun; 44(5):1227-30. PubMed ID: 22663990
    [Abstract] [Full Text] [Related]

  • 15. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH.
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [Abstract] [Full Text] [Related]

  • 16. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 17. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 18. Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation.
    Balachandran VP, Aull MJ, Charlton M, Afaneh C, Serur D, Leeser DB, Del Pizzo J, Kapur S.
    Transplantation; 2012 Sep 15; 94(5):499-505. PubMed ID: 22892992
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 15; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 20. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM.
    Gastroenterology; 2011 Oct 15; 141(4):1212-9. PubMed ID: 21762659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.